Aardvark Therapeutics

Forecast & Rating12 analysts currently cover Aardvark Therapeutics, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $14.50, about 129.4% upside from the current price of $6.32. Price targets range from $3.00 to $45.00 — a wide spread, showing clear disagreement over just how much Aardvark Therapeutics can rise. For you, this means institutional views on Aardvark Therapeutics are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 25, 2026; for reference only and not investment advice.